| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $48.0M | -53.8% |
| R&D Expense | $96.8M | +88.1% |
| SG&A Expense | $23.7M | -7.2% |
| Operating Income | -$73.4M | -441.5% |
| Pre-tax Income | -$68.6M | -369.9% |
| Income Tax | $0 | -100.0% |
| Net Income | -$68.6M | -400.6% |
| EPS (Basic) | -$1.27 | -395.3% |
| EPS (Diluted) | -$1.27 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.9M | -30.7% |
| Current Assets | $107.3M | -18.2% |
| Total Assets | $110.5M | -39.4% |
| Current Liabilities | $49.1M | +32.1% |
| Total Liabilities | $64.4M | -14.7% |
| Stockholders' Equity | $46.1M | -56.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.4M | +28.9% |
| Financing Cash Flow | $0 | -100.0% |
| -395.3% |